Top-Thema

15.12.17
ROUNDUP/Aktien New York Schluss: Aussicht auf Steuerreform lässt Rekorde purzeln

Neovasc to Present at the Leerink Partners Global Healthcare Conference

Mittwoch, 15.02.2017 13:05 von PR Newswire

PR Newswire

NASDAQ: NVCN
TSX: NVC

VANCOUVER, Feb. 15, 2017 /PRNewswire/ - Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ: NVCN) (TSX: NVC) today announced that Alexei Marko, chief executive officer, is scheduled to present at the LEERINK Partners 6th Annual Global Healthcare Conference on Thursday, February 16th at 9:00 am ET at the Lotte New York Palace in New York City.

A live audio webcast of the presentation will be available on the Investors page of Neovasc's website at www.neovasc.com.

About Neovasc Inc. 
Neovasc is a specialty medical device company that develops, manufactures and markets products for the rapidly growing cardiovascular marketplace.  Its products include the Neovasc Reducer™, for the treatment of refractory angina which is not currently available in the U.S. and has been available in Europe since 2015 and the Tiara™, for the transcatheter treatment of mitral valve disease, which is currently under investigation in the U.S., Canada and Europe. The Company also sells a line of advanced biological tissue products that are used as key components in third-party medical products including transcatheter heart valves. For more information, visit: www.neovasc.com.

SOURCE Neovasc Inc.